Breaking News

Avara Acquires AstraZeneca Facility in France

Expands capacity with secondary solid dosage form manufacturing, packaging and distribution site

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avara Pharmaceutical Services, an international pharmaceutical services company, has signed an agreement with AstraZeneca to acquire its Reims, France manufacturing and distribution facility.   “This key acquisition is another important component of our strategic plan that further expands our services,” said Timothy C. Tyson, Chairman and CEO.   Avara provides both API formulation and manufacturing, along with secondary formulation, manufacturing, packaging and distribution of sm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters